April 2021

Bionics

The AtonRâ Partners Bionics is a long-only, USD-based, actively managed certificate.

Bionics, through the merger of biology and electronics, improve the quality and lifespan of the world population. The theme continues to benefit from long-term drivers, notably an ageing world population, a shortage of donated organs, and technological advancements.

Technology plays a significant role in healthcare, improving productivity, lowering healthcare costs and making human enhancement a reality.

The investment universe encompasses next-generation prosthetics, medical wearables and devices, surgical robots, exoskeletons, 3D printing, synthetic biology and artificial intelligence, all playing a major role in the emergence of bionics.

Main Features
Asset Class Equity
Legal Structure Actively Managed Certificate
Investment Strategy Long
Launch date 12-Jan-17
Currency USD
Type of Return Total return
Ticker NXSRBION
isin XS1317063912
Issuer Natixis
Issue Price 100
Last Price 245.48
Sharpe Ratio 1.20
Correlation 0.77
Beta 1.13
Reference Index MSCI World Health Care Net (USD)
Liquidity Daily
# Holdings 22
Management Fees 1.30%
Issuer Fees 0.35%
Performance Fees 15.00%
ALL TIME HIGH ALL TIME LOW
PRICE: 270.5 PRICE: 99.1
DATE: 12-Feb-21 DATE: 23-Jan-17

Bionics

The AtonRâ Partners Bionics is a long-only, USD-based, actively managed certificate.

Bionics, through the merger of biology and electronics, improve the quality and lifespan of the world population. The theme continues to benefit from long-term drivers, notably an ageing world population, a shortage of donated organs, and technological advancements.

Technology plays a significant role in healthcare, improving productivity, lowering healthcare costs and making human enhancement a reality.

The investment universe encompasses next-generation prosthetics, medical wearables and devices, surgical robots, exoskeletons, 3D printing, synthetic biology and artificial intelligence, all playing a major role in the emergence of bionics.

Monthly Returns $

(Net of fees)

* Estimated
* Actual

JAN FEB MAR APR MAY JUN JUL AUG SEP OCT NOV DEC ANNUAL
2021 4.6% -4.6% -3.5% 8.3% 4.3%
2020 -0.2% -5.4% -6.8% 14.7% 7.6% -0.0% 10.7% 3.5% 3.3% -3.3% 9.6% 6.3% 44.8%
2019 9.7% 7.6% -0.1% -3.8% -2.1% 8.3% -0.3% -0.7% -0.1% 1.1% 7.1% -0.4% 28.1%
2018 9.7% -2.9% 0.7% 2.5% 5.9% 0.2% 3.5% 5.8% 3.9% -12.5% 5.5% -10.7% 9.5%
2017 -0.2% 4.3% 2.2% 3.0% 2.9% 2.7% -2.4% 2.4% -1.9% 1.7% 3.2% -2.6% 16.0%
Industry Exposure

Top 3 Holdings
  • GUARDANT HEALTH INC
  • SHOCKWAVE MEDICAL INC
  • INSULET CORP
Top 3 Contributors
  • NOVOCURE LTD
  • SHOCKWAVE MEDICAL INC
  • INSULET CORP
Worst 3 Contributors
  • BUTTERFLY NETWORK INC
  • TELADOC HEALTH INC
  • PACIFIC BIOSCIENCES OF CALIF
Geographical
Breakdown
Currency
Exposure
Asset
Allocation
Market Cap
Distribution
Equity
Liquidity*

*On average 3 Months daily trading volume

Risk
Scale

4


The actual risk can vary significantly if you cash in at an early stage and you may get back less. You may not be able to sell your product easily or you may have to sell at a price that significantly impacts on how much you get back

Industry Exposure